ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Low-sodium diet with standard bread
Low-sodium diet with low-sodium bread
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring salt intake, functional food, low-salt bread, blood pressure
Eligibility Criteria
Inclusion Criteria:
- arterial hypertension stage I-II
- stable control of blood pressure
- eGFR > 60
- informed consent signed
Exclusion Criteria:
- uncontrolled hypertension
- therapy with diuretics
- need for therapy with more than three antihypertensive drugs
- proteinuria greater than 1 g/day
- celiac disease
- systemic inflammatory diseases
- suspicion or clinical diagnosis of malignancy
- chronic liver disease
- treatment with corticosteroids or immunosuppressive drugs
- previous acute cardiovascular diseases (myocardial infarction, stroke)
- psychiatric conditions reducing the compliance to treatment protocols
Sites / Locations
- AUO Policlinico Consorziale
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Active Comparator
Experimental
Arm Label
A - control
B - low-salt diet with normal bread
C - low-salt diet with low-salt bread
Arm Description
Free diet with standard bread
Low-sodium diet with standard bread
Low-sodium diet with low-sodium bread
Outcomes
Primary Outcome Measures
Sodium intake
Reduction of sodium intake in diet with the introduction of the innovative formulation of low-salt bread
Secondary Outcome Measures
Blood pressure
Reduction of blood pressure
Endothelial stress
Improvement of flow-mediated dilation FMD
Gut microbiota
Evaluation of gut microbiota modulation
Antioxidant status
Evaluation of the antioxidant/oxidant ratio of blood
Inflammation
State of sub-clinical inflammation
Insulin sensitivity
Reduction of insulin sensitivity
Full Information
NCT ID
NCT03127553
First Posted
April 10, 2017
Last Updated
April 20, 2017
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborators
Ospedali Riuniti di Foggia
1. Study Identification
Unique Protocol Identification Number
NCT03127553
Brief Title
ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)
Official Title
Technological and Clinical Innovative Protocols for the Production of Functional Foods - 6.7 (ProAliFun67)
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
December 2014 (Actual)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
August 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborators
Ospedali Riuniti di Foggia
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this clinical study is to evaluate the health properties of a dietary intervention carried on with an innovative low-salt bread.
The hypothesis is that the introduction of a low-sodium bread as part of a low-salt diet may improve the compliance to the own regime and that the vascular function, the inflammatory and oxidative state, the composition of the intestinal microbiota and that neurocognitive and neurodegenerative processes can improve in hypertensive patients fed a low-salt diet with low-salt bread.
Detailed Description
This clinical trial is a multi-center, randomized, controlled, open label, pilot study, lasting 6 months.
A target number of seventy individuals with hypertension meeting inclusion and exclusion criteria, assessed at enrollment, and which have signed the informed consent, will be recruited.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
salt intake, functional food, low-salt bread, blood pressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
57 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A - control
Arm Type
No Intervention
Arm Description
Free diet with standard bread
Arm Title
B - low-salt diet with normal bread
Arm Type
Active Comparator
Arm Description
Low-sodium diet with standard bread
Arm Title
C - low-salt diet with low-salt bread
Arm Type
Experimental
Arm Description
Low-sodium diet with low-sodium bread
Intervention Type
Dietary Supplement
Intervention Name(s)
Low-sodium diet with standard bread
Intervention Description
low-sodium diet (2300 mg Na/die) with use of standard bread (750 mg Na/100g) for 6 months
Intervention Type
Dietary Supplement
Intervention Name(s)
Low-sodium diet with low-sodium bread
Intervention Description
low-sodium diet (2300 mg Na/die) with use of low-salt bread (280 mg Na/100g) for 6 months
Primary Outcome Measure Information:
Title
Sodium intake
Description
Reduction of sodium intake in diet with the introduction of the innovative formulation of low-salt bread
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Blood pressure
Description
Reduction of blood pressure
Time Frame
6 months
Title
Endothelial stress
Description
Improvement of flow-mediated dilation FMD
Time Frame
6 months
Title
Gut microbiota
Description
Evaluation of gut microbiota modulation
Time Frame
6 months
Title
Antioxidant status
Description
Evaluation of the antioxidant/oxidant ratio of blood
Time Frame
6 months
Title
Inflammation
Description
State of sub-clinical inflammation
Time Frame
6 months
Title
Insulin sensitivity
Description
Reduction of insulin sensitivity
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
arterial hypertension stage I-II
stable control of blood pressure
eGFR > 60
informed consent signed
Exclusion Criteria:
uncontrolled hypertension
therapy with diuretics
need for therapy with more than three antihypertensive drugs
proteinuria greater than 1 g/day
celiac disease
systemic inflammatory diseases
suspicion or clinical diagnosis of malignancy
chronic liver disease
treatment with corticosteroids or immunosuppressive drugs
previous acute cardiovascular diseases (myocardial infarction, stroke)
psychiatric conditions reducing the compliance to treatment protocols
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Loreto Gesualdo, MD Full Prof
Organizational Affiliation
Head of the Nephrology, Dialysis and Transplantation Unit "Aldo Moro" University of Bari Azienda Ospedaliero-Universitaria Consorziale "Policlinico"
Official's Role
Principal Investigator
Facility Information:
Facility Name
AUO Policlinico Consorziale
City
Bari
State/Province
BA
ZIP/Postal Code
70125
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)
We'll reach out to this number within 24 hrs